Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) EPS (Weighted Average and Diluted) (2016 - 2025)

Phibro Animal Health has reported EPS (Weighted Average and Diluted) over the past 13 years, most recently at $0.67 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.67 for Q4 2025, up 737.5% from a year ago — trailing twelve months through Dec 2025 was $2.26 (up 370.83% YoY), and the annual figure for FY2025 was $1.19, up 1883.33%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $0.67 at Phibro Animal Health, up from $0.65 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for PAHC hit a ceiling of $0.67 in Q4 2025 and a floor of -$0.2 in Q3 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.23 (2024), compared with a mean of $0.27.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 300.0% in 2023 and later surged 2050.0% in 2025.
  • Phibro Animal Health's EPS (Weighted Average and Diluted) stood at $0.43 in 2021, then crashed by 58.14% to $0.18 in 2022, then plummeted by 83.33% to $0.03 in 2023, then skyrocketed by 166.67% to $0.08 in 2024, then surged by 737.5% to $0.67 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.67 (Q4 2025), $0.65 (Q3 2025), and $0.43 (Q2 2025) per Business Quant data.